BIOLINERX
Careers | Contact Us
search

Press Releases
May 20, 2014
Company Poised to Execute on Multiple Clinical Milestones
May 15, 2014
Management to hold a conference call at 10:00 a.m. EDT
April 10, 2014
Phase 1/2 study will assess effect of BL-8040 in combination with standard therapy

March 14, 2014

BL-8040 currently undergoing Phase 2 trial for acute myeloid leukemia (AML), and expected to commence Phase 1 trial in stem cell mobilization in Q2 2014

Top-line results from both trials expected in next 9-12 months
March 11, 2014
Management to hold conference call at 10:00 a.m. EDT
March 10, 2014
Single administration of BL-7010 was safe and well tolerated at all doses tested 

BL-7010 now advancing to repeated administration part of study; results expected mid 2014


161-170  Out of  309 Previous
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 
 16   17   18   19   20   21   22   23   24   25   26   27   28   29 
 30   31 
Next